These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29637404)

  • 41. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.
    Wright P; Lindborg SR; Birkett M; Meehan K; Jones B; Alaka K; Ferchland-Howe I; Pickard A; Taylor CC; Roth J; Battaglia J; Bitter I; Chouinard G; Morris PL; Breier A
    Can J Psychiatry; 2003 Dec; 48(11):716-21. PubMed ID: 14733451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Retrospective Analysis of Steady-State Olanzapine Concentrations in Chinese Patients Using Therapeutic Drug Monitoring: Effects of Valproate and Other Factors.
    Deng SH; Wang ZZ; Lu HY; Li L; Hu JQ; Zhu XQ; Xie HS; Chen HZ; Zhang M; Ni XJ; Qiu C; Shang DW; Wen YG
    Ther Drug Monit; 2020 Aug; 42(4):636-642. PubMed ID: 32039940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benefit of extending the dosing interval of olanzapine on schizophrenics during maintenance treatment.
    Suzuki H; Hibino H; Inoue Y; Mikami A; Matsumoto H; Mikami K
    Asian J Psychiatr; 2017 Dec; 30():100-101. PubMed ID: 28858761
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacoeconomic evaluation of schizophrenia in Taiwan: model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs.
    Yang YK; Tarn YH; Wang TY; Liu CY; Laio YC; Chou YH; Lee SM; Chen CC
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):385-94. PubMed ID: 16048443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study.
    Jones ME; Andrews JS; Faries DE; Landry J; Xu J; Detke HC; Chhabra-Khanna R; McDonnell DP
    BMC Psychiatry; 2015 Nov; 15():278. PubMed ID: 26567159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paliperidone palmitate use in pregnancy in a woman with schizophrenia.
    Özdemir AK; Pak ŞC; Canan F; Geçici Ö; Kuloğlu M; Gücer MK
    Arch Womens Ment Health; 2015 Oct; 18(5):739-40. PubMed ID: 25599999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postinjection Delirium/Sedation Syndrome After 31st Long-Acting Olanzapine Depot Injection.
    Venkatesan V; Khanra S; Mandal K; Deepak MB
    Clin Neuropharmacol; 2019; 42(2):64-65. PubMed ID: 30747749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Post-injection delirium/sedation syndrome following injection of olanzapine pamoate: a new syndrome in emergency psychiatry].
    Buts K; Van Hecke J
    Tijdschr Psychiatr; 2014; 56(4):273-6. PubMed ID: 24807388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of olanzapine long-acting injection and oral olanzapine: a 2-year, randomized, open-label study in outpatients with schizophrenia.
    Detke HC; Weiden PJ; Llorca PM; Choukour M; Watson SB; Brunner E; Ascher-Svanum H
    J Clin Psychopharmacol; 2014 Aug; 34(4):426-34. PubMed ID: 24781441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance.
    Brunner E; Falk DM; Jones M; Dey DK; Shatapathy CC
    BMC Pharmacol Toxicol; 2013 Aug; 14():38. PubMed ID: 23902726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risperidone and breast-feeding.
    Aichhorn W; Stuppaeck C; Whitworth AB
    J Psychopharmacol; 2005 Mar; 19(2):211-3. PubMed ID: 15728443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perinatal use of aripiprazole: a case report.
    Watanabe N; Kasahara M; Sugibayashi R; Nakamura T; Nakajima K; Watanabe O; Murashima A
    J Clin Psychopharmacol; 2011 Jun; 31(3):377-9. PubMed ID: 21532364
    [No Abstract]   [Full Text] [Related]  

  • 53. Relationship between antipsychotic blood levels and treatment failure during the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
    Melkote R; Singh A; Vermeulen A; Remmerie B; Savitz A
    Schizophr Res; 2018 Nov; 201():324-328. PubMed ID: 29804929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis.
    Arnaiz JA; Rodrigues-Silva C; Mezquida G; Amoretti S; Cuesta MJ; Fraguas D; Lobo A; González-Pinto A; Díaz-Caneja MC; Corripio I; Vieta E; Baeza I; Mané A; García-Rizo C; Bioque M; Saiz J; Bernardo M; Mas S;
    Psychopharmacology (Berl); 2021 Mar; 238(3):665-676. PubMed ID: 33230696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
    Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
    Eur J Pharm Sci; 2017 Jun; 104():315-325. PubMed ID: 28408348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania.
    Chandrasena R; Dvoráková D; Lee SI; Loza N; Mosolov SN; Osváth P; Pregelj P; Walton RJ; Karagianis J; Treuer T
    Int J Clin Pract; 2009 Aug; 63(8):1249-58. PubMed ID: 19558486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antipsychotics and breastfeeding.
    Winans EA
    J Hum Lact; 2001 Nov; 17(4):344-7. PubMed ID: 11847903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic Drug Monitoring of Olanzapine and Cytochrome P450 Genotyping in Nonsmoking Subjects.
    Miroshnichenko II; Pozhidaev IV; Ivanova SA; Baymeeva NV
    Ther Drug Monit; 2020 Apr; 42(2):325-329. PubMed ID: 31425442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical review of a long-acting, injectable formulation of risperidone.
    Knox ED; Stimmel GL
    Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-acting injectable antipsychotics in early psychosis: a literature review.
    Emsley R; Chiliza B; Asmal L; Mashile M; Fusar-Poli P
    Early Interv Psychiatry; 2013 Aug; 7(3):247-54. PubMed ID: 23342964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.